ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
4,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,1,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
6,1,Congenital cerebrovascular anomaly,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
6,2,Congenital optic nerve anomaly,Optic nerve and optic disc disorders congenital,Eye disorders congenital,Cong,N
6,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
7,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
7,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
7,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
8,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
9,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
10,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
10,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
11,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
12,1,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Bacterial vaginosis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
15,2,Retained products of conception,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
16,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
16,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
19,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,3,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
19,4,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
20,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
20,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
21,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
21,2,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
22,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
22,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
23,1,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
23,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
23,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
24,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
25,2,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
26,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
27,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
28,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
28,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
28,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
29,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
29,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
30,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,3,Phimosis,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
32,1,Genital burning sensation,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
32,2,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
32,3,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
33,1,Genital blister,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
33,2,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
33,3,Phimosis,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
33,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
34,2,Drug administered in wrong device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
34,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
35,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
36,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
37,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
37,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
37,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
37,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
38,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
38,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
39,1,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
40,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
40,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
40,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
40,4,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
41,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
46,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
47,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
47,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,1,Genital hyperaesthesia,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
49,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
50,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
50,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
51,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
51,3,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
51,4,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
51,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
54,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
55,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
55,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
55,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
55,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
55,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
56,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
57,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
59,1,Perineal ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
60,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
